FREE SAMPLE ?
Please enter corporate email id here & we’ll send you a free sample.
3D Bioprinting Market by Product (Bioprinter [Extrusion, Laser, SLA, FDM, SLS], Bioinks, Materials [Hydrogels, Cells, Biomaterials], Software, Accessories) Application (Cancer Research, Tissue Engineering, Drug Discovery) End User - Global Forecast to 2030
Report ID: MRHC - 1041063 Pages: 250 Dec-2023 Formats*: PDF Category: Healthcare Delivery: 24 to 72 Hours Download Free Sample Report
The 3D Bioprinting Market is projected to reach $5.21 billion by 2030, at a CAGR of 17.1% from 2023 to 2030. 3D Bioprinting is a technique that employs biomaterials and cells compared to traditional polymers and metals to generate functional 3D tissues. The 3D Bioprinting incorporates pre-bioprinting, bioprinting, and post-bioprinting. This technology is employed in various research areas, such as regenerative medicines, cancer research, tissue engineering, and many others. Numerous bioprinting techniques have been developed, such as inkjet printheads, laser-induced methods, acoustic wave methods, applied pressure, and solenoid valve-based methods, to deposit cells onto substrates. The preference for 3D bioprinting is growing compared to conventional bioprinting techniques due to its ability to digitally define tissue constructs and reproduce complex 3D structures using automated processes, achieving resolutions not feasible with traditional methods.
The growth of this market is driven by factors such as technological advancements in 3D bioprinting, the rising geriatric population coupled with the growing burden of chronic diseases, and increasing R&D investments. Additionally, the increasing demand for organ transplantation is expected to offer significant market growth opportunities.
However, the lack of skilled professionals and the high costs associated with 3D bioprinting restrain the growth of this market. Additionally, concerns regarding intellectual property rights and safety issues associated with the use of 3D bioprinted products are some of the challenges impeding the market's growth.
There has been a continuous rise in the geriatric population due to rising life expectancy, improved healthcare quality, urbanization, and growing income levels, leading to greater survival rates. According to the United Nations, there were 727 million people aged 65 years or over globally in 2020. The global share of the aged population (65 years or over) is expected to increase from 9.3% (727 million) in 2020 to 16.0% (1,548.9 million) in 2050, i.e., one in four persons living in Europe and North America could be aged 65 years or over. This remarkable growth in the geriatric population is also driven by declining fertility rates and improvements in longevity.
Additionally, with the rapid growth in the global geriatric population, cases of age-related chronic diseases are expected to increase globally. This demographic shift is leading to the increased prevalence of various chronic diseases. According to the Centers for Disease Control and Prevention (CDC), in 2022, six in ten people in the U.S. had at least one chronic disease, such as cardiovascular disease, cancer, and diabetes. Furthermore, according to the GLOBOCAN, in 2020, 19.3 million cancer cases were diagnosed all over the world. It is expected to increase up to 24.5 million by 2030.
Thus, the increasing geriatric population, coupled with the growing burden of chronic diseases, drives the 3D bioprinting market.
Over the past decade, there has been a significant increase in the demand for organ transplantation. This growth in demand can be attributed to factors such as the rising incidence of organ failure, the high success rate of transplant procedures, and improved post-transplant outcomes. Metabolic diseases, including diabetes, high blood pressure, heart disease, and metabolic syndrome, are the primary causes of organ failure. The prevalence of these diseases has contributed to a higher number of organ transplant cases.
According to the Health Resources and Services Administration (HRSA), in 2022, 1 million organs were transplanted worldwide, out of which 104,234 women, men, and children were on the waiting list. Liver transplantation is necessary when the liver fails due to various reasons, including alcoholic liver disease, hepatitis, metabolic diseases, and other liver diseases. According to GLOBOCAN, 905,677 cases of liver cancer were detected in 2020. This number is projected to increase to 1.2 million by 2030. The rising incidence of liver cancer underscores the need for liver transplantation. 3D bioprinting enables the generation of bioengineered liver organoids and tissues from patients' own cells, reducing the possibility of rejection and eliminating the requirement for immunosuppressive drugs, which are frequently required after conventional organ transplantation.
Among the products, in 2023, the bioprinters segment is expected to account for the largest share of the 3D bioprinting market. 3D bioprinters produce tissues and organ patches using a patient's own cells, which can reduce the risk of rejection, enable personalized treatments, and decrease reliance on animal testing. Additionally, technological advancements in 3D bioprinters have enabled researchers to explore diverse applications and streamline the development process. These factors contribute to the large market share of this segment.
Among the applications, in 2023, the cancer research segment is expected to account for the largest share of the 3D bioprinting market. The large market share of this segment is attributed to the rising prevalence of cancer. According to GLOBOCAN, in 2020, 19.3 million cancer cases were diagnosed all over the world. The number of cases is expected to increase to 24.5 million by 2030. Cancer models that replicate the tumor microenvironment are produced using 3D bioprinting, assisting researchers with cancer medication screening and contributing to a greater understanding of cancer.
Among the end users, in 2023, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the 3D bioprinting market. The large market share of this segment is attributed to rising collaborations between pharmaceutical companies and 3D bioprinting providers to reduce global organ shortages. For Instance, in September 2020, CollPlant Biotechnologies (Israel) collaborated with United Therapeutics Corporation (U.S.) to reduce global organ shortages of kidney transplants and save the lives of millions of patients on kidney waiting lists.
The market in Asia-Pacific is projected to register the highest CAGR during the forecast period. The growth of this regional market is attributed to the increasing incidence of cancer, the presence of key 3D bioprinting companies in countries like China, India, Singapore, and Japan, advancements in 3D bioprinting technology such as improved vascularization of printed tissues, and government investments in research and development activities.
The report offers a competitive landscape based on an extensive assessment of the offerings and geographic presence of leading market players and the key growth strategies adopted by them over the past three to four years. The key players profiled in the 3D bioprinting market report are Organovo Holdings Inc. (U.S.), BICO Group AB (Sweden), Aspect Biosystems Ltd. (Canada), Cyfuse Biomedical K.K. (Japan), Advanced Solutions Life Sciences, LLC (U.S.), CollPlant Biotechnologies Ltd. (Israel), regenHU Ltd. (Switzerland), Poietis (France), REGEMAT 3D, SL (Spain), 3DBio Therapeutics (U.S.), and Foldink Life Science Technologies (Armenia).
|
Particulars |
Details |
|
Number of Pages |
~250 |
|
Format |
|
|
Forecast Period |
2023-2030 |
|
Base Year |
2022 |
|
CAGR |
17.1% |
|
Estimated Market Size (Value) |
$5.21 billion by 2030 |
|
Segments Covered |
By Product
By Application
By End User
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, Italy, U.K., Spain, Belgium, Switzerland, Netherlands, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa. |
|
Key Companies |
Organovo Holdings Inc. (U.S.), BICO Group AB (Sweden), Aspect Biosystems Ltd. (Canada), Cyfuse Biomedical K.K. (Japan), Advanced Solutions Life Sciences, LLC (U.S.), CollPlant Biotechnologies Ltd. (Israel), regenHU Ltd. (Switzerland), Poietis (France), REGEMAT 3D, SL (Spain), 3D Bioprinting Solutions (Russia), and Foldink Life Science Technologies (Armenia). |
This study offers a detailed assessment of the 3D bioprinting market and analyzes the market sizes & forecasts based on product, application, and end user. This report also involves the value analysis of various segments and subsegments of the 3D Bioprinting market at the regional and country levels.
The 3D Bioprinting market is projected to reach $5.21 billion by 2030, at a CAGR of 17.1% during the forecast period.
Among the products, in 2023, the bioprinters segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the technological advancements of 3D bioprinting and the high adoption of these printers among research institutes.
The growth of this market is driven by factors such as technological advancements in 3D bioprinting, the rising geriatric population coupled with the growing burden of chronic diseases, and increasing R&D investments. Additionally, the increasing demand for organ transplantation is expected to offer significant market growth opportunities.
The key players profiled in the 3D bioprinting market report are Organovo Holdings Inc. (U.S.), BICO Group AB (Sweden), Aspect Biosystems Ltd. (Canada), Cyfuse Biomedical K.K. (Japan), Advanced Solutions Life Sciences, LLC (U.S.), CollPlant Biotechnologies Ltd. (Israel), regenHU Ltd. (Switzerland), Poietis (France), REGEMAT 3D, SL (Spain), 3D Bioprinting Solutions (Russia), and Foldink Life Science Technologies (Armenia).
Emerging economies, such as China and India, are expected to provide significant growth opportunities for market players due to the increasing R&D spending in these countries.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Technological Advancements in 3D Bioprinting
4.2.2. Rising Geriatric Population, Coupled with the Growing Burden of Chronic Diseases
4.2.3. Increasing R&D Investments
4.3. Restraints
4.3.1. Lack of Skilled Professionals
4.3.2. High Costs Associated with 3D Bioprinting
4.4. Opportunities
4.4.1. Increasing Demand for Organ Transplantation
4.5. Challenges
4.5.1. Concerns Regarding Intellectual Property Rights
4.5.2. Safety Issues Associated With the Use of 3D Bioprinted Products
4.6. Factor Analysis
4.7. Pricing Analysis
4.8. Technology Trends
4.9. Regulatory Analysis
4.10. Porter’s Five Forces Analysis
5. 3D Bioprinting Market Assessment—by Product
5.1. Overview
5.2. Bioprinters
5.2.1. Inkjet-based
5.2.2. Extrusion-based
5.2.3. Stereolithography (SLA)
5.2.4. Laser-based
5.2.5. Fused-deposition modeling (FDM)
5.2.6. Selective laser sintering (SLS)
5.2.7. Other Technologies
5.3. Bioinks
5.3.1. Natural
5.3.2. Synthetic
5.3.3. Hybrid
5.4. Materials
5.4.1. Hydrogels
5.4.2. Living Cells
5.4.3. Extracellular Matrices
5.4.4. Biomaterials
5.4.5. Other Materials
5.5. Software
5.6. Accessories and Consumables
6. 3D Bioprinting Assessment—by Application
6.1. Overview
6.2. Cancer Research
6.3. Regenerative Medicines
6.4. Drug Discovery and Testing
6.5. Tissue Engineering
6.6. Biomaterials and cells research
6.7. Other Applications
7. 3D Bioprinting Assessment—by End User
7.1. Overview
7.2. Pharmaceutical and Biotechnology Companies
7.3. Academic and Research Institutes
7.4. Contract Research Organizations (CROs)
8. 3D Bioprinting Market Assessment—by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Belgium
8.3.7. Switzerland
8.3.8. Netherlands
8.3.9. Rest of Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. South Korea
8.4.6. Rest of Asia-Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America
8.6. Middle East & Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis/Market Rankings, by Key Players (2022)
10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments, and SWOT Analysis*)
10.1. Organovo Holdings Inc.
10.2. BICO Group AB
10.3. Aspect Biosystems Ltd.
10.4. Cyfuse Biomedical K.K.
10.5. Advanced Solutions Life Sciences, LLC
10.6. CollPlant Biotechnologies Ltd.
10.7. regenHU Ltd.
10.8. Poietis
10.9. REGEMAT 3D, SL
10.10. 3D Bioprinting Solutions
10.11. Foldink Life Science Technologies
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Global 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 2 Global 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 3 Global 3D Bioprinting Market for Bioprinters, by Country/Region, 2021–2030 (USD Million)
Table 4 Global Inkjet-based 3D Bioprinters Market, by Country/Region, 2021–2030 (USD Million)
Table 5 Global Extrusion-based 3D Bioprinters Market, by Country/Region, 2021–2030 (USD Million)
Table 6 Global Stereolithography (SLA) 3D Bioprinters Market, by Country/Region, 2021–2030 (USD Million)
Table 7 Global Laser-based 3D Bioprinters Market, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Fused-deposition modeling (FDM) 3D Bioprinters Market, by Country/Region, 2021–2030 (USD Million)
Table 9 Global Selective laser sintering (SLS) 3D Bioprinters Market, by Country/Region, 2021–2030 (USD Million)
Table 10 Global 3D Bioprinters Market for Other Technologies, by Country/Region, 2021–2030 (USD Million)
Table 11 Global 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 12 Global 3D Bioprinting Market for Bioinks, by Country/Region, 2021–2030 (USD Million)
Table 13 Global 3D Bioprinting Market for Natural Bioinks, by Country/Region, 2021–2030 (USD Million)
Table 14 Global 3D Bioprinting Market for Synthetic Bioinks, by Country/Region, 2021–2030 (USD Million)
Table 15 Global 3D Bioprinting Market for Hybrid Bioinks, by Country/Region, 2021–2030 (USD Million)
Table 16 Global 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 17 Global 3D Bioprinting Market for Materials, by Country/Region, 2021–2030 (USD Million)
Table 18 Global 3D Bioprinting Market for Hydrogels, by Country/Region, 2021–2030 (USD Million)
Table 19 Global 3D Bioprinting Market for Living Cells, by Country/Region, 2021–2030 (USD Million)
Table 20 Global 3D Bioprinting Market for Extracellular Matrices, by Country/Region, 2021–2030 (USD Million)
Table 21 Global 3D Bioprinting Market for Biomaterials, by Country/Region, 2021–2030 (USD Million)
Table 22 Global 3D Bioprinting Market for Other Materials, by Country/Region, 2021–2030 (USD Million)
Table 23 Global 3D Bioprinting Market for Software, by Country/Region, 2021–2030 (USD Million)
Table 24 Global 3D Bioprinting Market for Accessories and Consumables, by Country/Region, 2021–2030 (USD Million)
Table 25 Global 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 26 Global 3D Bioprinting Market for Cancer Research, by Country/Region, 2021–2030 (USD Million)
Table 27 Global 3D Bioprinting Market for Regenerative Medicines, by Country/Region, 2021–2030 (USD Million)
Table 28 Global 3D Bioprinting Market for Drug Discovery and Testing, by Country/Region, 2021–2030 (USD Million)
Table 29 Global 3D Bioprinting Market for Tissue Engineering, by Country/Region, 2021–2030 (USD Million)
Table 30 Global 3D Bioprinting Market for Biomaterials and Cells research, by Country/Region, 2021–2030 (USD Million)
Table 31 Global 3D Bioprinting Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 32 Global 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 33 Global 3D Bioprinting Market for Pharmaceutical and Biotechnology Companies, by Country/Region, 2021–2030 (USD Million)
Table 34 Global 3D Bioprinting Market for Academic and Research Institutes, by Country/Region, 2021–2030 (USD Million)
Table 35 Global 3D Bioprinting Market for Contract Research Organizations (CROs), by Country/Region, 2021–2030 (USD Million)
Table 36 Global 3D Bioprinting Market, by Country/Region, 2021–2030 (USD Million)
Table 37 North America: 3D Bioprinting Market, by Country, 2021–2030 (USD Million)
Table 38 North America: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 39 North America: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 40 North America: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 41 North America: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 42 North America: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 43 North America: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 44 U.S.: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 45 U.S.: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 46 U.S.: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 47 U.S.: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 48 U.S.: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 49 U.S.: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 50 Canada: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 51 Canada: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 52 Canada: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 53 Canada: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 54 Canada: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 55 Canada: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 56 Europe: 3D Bioprinting Market, by Country/Region, 2021–2030 (USD Million)
Table 57 Europe: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 58 Europe: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 59 Europe: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 60 Europe: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 61 Europe: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 62 Europe: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 63 Germany: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 64 Germany: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 65 Germany: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 66 Germany: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 67 Germany: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 68 Germany: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 69 France: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 70 France: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 71 France: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 72 France: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 73 France: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 74 France: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 75 U.K.: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 76 U.K.: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 77 U.K.: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 78 U.K.: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 79 U.K.: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 80 U.K.: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 81 Italy: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 82 Italy: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 83 Italy: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 84 Italy: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 85 Italy: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 86 Italy: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 87 Spain: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 88 Spain: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 89 Spain: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 90 Spain: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 91 Spain: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 92 Spain: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 93 Belgium: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 94 Belgium: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 95 Belgium: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 96 Belgium: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 97 Belgium: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 98 Belgium: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 99 Switzerland: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 100 Switzerland: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 101 Switzerland: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 102 Switzerland: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 103 Switzerland: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 104 Switzerland: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 105 Netherlands: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 106 Netherlands: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 107 Netherlands: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 108 Netherlands: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 109 Netherlands: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 110 Netherlands: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 111 Rest of Europe: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 112 Rest of Europe: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 113 Rest of Europe: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 114 Rest of Europe: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 115 Rest of Europe: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 116 Rest of Europe: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 117 Asia-Pacific: 3D Bioprinting Market, by Country/Region, 2021–2030 (USD Million)
Table 118 Asia-Pacific: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 119 Asia-Pacific: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 120 Asia-Pacific: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 121 Asia-Pacific: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 122 Asia-Pacific: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 123 Asia-Pacific: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 124 China: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 125 China: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 126 China: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 127 China: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 128 China: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 129 China: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 130 Japan: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 131 Japan: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 132 Japan: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 133 Japan: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 134 Japan: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 135 Japan: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 136 India: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 137 India: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 138 India: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 139 India: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 140 India: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 141 India: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 142 Australia: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 143 Australia: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 144 Australia: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 145 Australia: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 146 Australia: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 147 Australia: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 148 South Korea: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 149 South Korea: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 150 South Korea: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 151 South Korea: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 152 South Korea: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 153 South Korea: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 154 Rest of Asia-Pacific: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 155 Rest of Asia-Pacific: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 156 Rest of Asia-Pacific: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 157 Rest of Asia-Pacific: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 158 Rest of Asia-Pacific: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 159 Rest of Asia-Pacific: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 160 Latin America: 3D Bioprinting Market, by Country/Region, 2021–2030 (USD Million)
Table 161 Latin America: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 162 Latin America: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 163 Latin America: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 164 Latin America: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 165 Latin America: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 166 Latin America: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 167 Brazil: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 168 Brazil: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 169 Brazil: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 170 Brazil: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 171 Brazil: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 172 Brazil: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 173 Mexico: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 174 Mexico: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 175 Mexico: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 176 Mexico: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 177 Mexico: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 178 Mexico: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 179 Rest of Latin America: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 180 Rest of Latin America: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 181 Rest of Latin America: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 182 Rest of Latin America: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 183 Rest of Latin America: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 184 Rest of Latin America: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 185 Middle East & Africa: 3D Bioprinting Market, by Product, 2021–2030 (USD Million)
Table 186 Middle East & Africa: 3D Bioprinting Market for Bioprinters, by Technology, 2021–2030 (USD Million)
Table 187 Middle East & Africa: 3D Bioprinting Market for Bioinks, by Type, 2021–2030 (USD Million)
Table 188 Middle East & Africa: 3D Bioprinting Market for Materials, by Type, 2021–2030 (USD Million)
Table 189 Middle East & Africa: 3D Bioprinting Market, by Application, 2021–2030 (USD Million)
Table 190 Middle East & Africa: 3D Bioprinting Market, by End User, 2021–2030 (USD Million)
Table 191 Recent Developments, by Company, 2020–2023
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 Global 3D Bioprinting Market, by Product, 2023 VS. 2030 (USD Million)
Figure 8 Global 3D Bioprinting Market, by Application, 2023 VS. 2030 (USD Million)
Figure 9 Global 3D Bioprinting Market, by End User, 2023 VS. 2030 (USD Million)
Figure 10 Global 3D Bioprinting Market, by Geography
Figure 11 Impact Analysis: 3D Bioprinting Market
Figure 12 Global 3D Bioprinting Market, by Product, 2023 VS. 2030 (USD Million)
Figure 13 Global 3D Bioprinting Market, by Application, 2023 VS. 2030 (USD Million)
Figure 14 Global 3D Bioprinting Market, by End User, 2023 VS. 2030 (USD Million)
Figure 15 Global 3D Bioprinting Market, by Geography, 2023 VS. 2030 (USD Million)
Figure 16 North America: 3D Bioprinting Market Snapshot
Figure 17 Europe: 3D Bioprinting Market Snapshot
Figure 18 Asia-Pacific: 3D Bioprinting Market Snapshot
Figure 19 Latin America: 3D Bioprinting Market Snapshot
Figure 20 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 21 Global 3D Bioprinting Market: Competitive Benchmarking, by Product
Figure 22 Global 3D Bioprinting Market: Competitive Benchmarking, by Geography
Figure 23 Global 3D Bioprinting Market: Vendor Dashboard
Figure 24 Market Share Analysis: Global 3D Bioprinting Market, 2022
Figure 25 Organovo Holdings Inc.: Financial Overview (2022)
Figure 26 BICO Group AB: Financial Overview (2022)
Figure 27 CollPlant Biotechnologies Ltd.: Financial Overview (2022)
Figure 28 Cyfuse Biomedical K.K.: Financial Overview (2022)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Jul-2023
Published Date: May-2023
Published Date: Feb-2023
Published Date: Jan-2023
Published Date: Jan-2023
